23+ hour, 14+ min ago   (105+ words) Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible Oncodaily Catharine Grimes: WCLC 2026 Focuses on Making Earlier Detection More Accessible Catharine Grimes, President of the Bristol Myers Squibb Foundation, shared on LinkedIn: “The World Conference on Lung Cancer begins…...

3+ day, 18+ hour ago   (130+ words) Discussions Around the DeLLphi-305 Trial FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer Hodgkin Lymphoma in 2026: What the New EHA Guidelines Recommend Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health…...

3+ day, 22+ hour ago   (148+ words) Gillian Ryan, Lung Cancer Patient Advocate at White Ribbon for Lung Cancer, shared on LinkedIn: “Cancer in Ireland and the numbers we need to talk about 10,000 people die of cancer in Ireland every year. Lung cancer kills more people in…...

6+ day, 20+ hour ago   (126+ words) Lung Cancer Europe shared on LinkedIn: “Changes after immunotherapy starts may be more informative than a sample taken before treatment begins. New research published in Cancer Cell looked at how the tumour immune environment changes during checkpoint inhibitor treatment. The…...

1+ week, 1+ hour ago   (163+ words) Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared on LinkedIn: “Thanks MSD Hong Kong for organising the Hong Kong iteration of Current Trends In Oncology (CTIO26). Always a pleasure meeting colleagues and friends from across the…...

1+ week, 2+ hour ago   (172+ words) Humam Kadara: Grateful to Receive a Breakthroughs Discovery Program Award at UT MD Anderson / Aria Vaishnavi, cancer, Ferdinandos Skoulidis, Humam Kadara, Jay, Aria Vaishnavi, cancer, Ferdinandos Skoulidis, Humam Kadara, Jay Zhang, Jia Wu, Johannes Fahrmann, Linghua Wang, Luisa Solis, Lung…...

1+ week, 1+ day ago   (203+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

1+ week, 2+ day ago   (263+ words) Victor Moreno, Director of Clinical Research at START Madrid FJD, shared on LinkedIn: “When a phase 1 trial enrols 395 patients, is it still really a phase 1 trial? A new Lancet Oncology paper reports the development of SHR-A2102, a nectin-4-directed antibody…...

1+ week, 4+ day ago   (201+ words) Vivian Salama, Assistant Professor at WVU Cancer Institute, shared on LinkedIn: “I am thrilled to share that our real-world Cardiovascular morbidity paper in Appalachian lung cancer population has been published at ‘Cancers; The State of The Art in CardioOncology.’ Our…...

1+ week, 4+ day ago   (120+ words) The Babak Lab shared on LinkedIn: “A new targeted option after ROS1 inhibitor resistance in lung cancer. On July 22, the FDA approved zidesamtinib (Jideytro) for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have already received…...